MRK vs CVS
By Alex · Tickerpine
Merck & Co., Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CVS |
|---|---|---|
| Price | $145.27 | $93.47 |
| Market cap | $358.41B | $119.55B |
| P/E ratio | 117.2 | 24.6 |
| ROE | 6.96% | 6.21% |
| Profit margin | 4.77% | 1.18% |
| Revenue growth | 5.10% | 7.10% |
| Dividend yield | 2.34% | 2.85% |
| Beta | 0.22 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CVS in plain English
- MRK is the bigger company — about 3.0× the market cap of CVS.
- CVS is cheaper on earnings (P/E 24.6 vs 117.2).
- MRK earns a higher return on equity (7% vs 6%).
- CVS is growing revenue faster (7% vs 5%).
- CVS has the higher dividend yield (2.85% vs 2.34%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.